Indication
Ductal carcinoma in situ of breast
Ductal carcinoma in situ of the breast is a non-invasive, pre-invasive neoplastic proliferation of epithelial cells originating within the breast’s ductal-lobular system. Read more about Ductal carcinoma in situ of breast
16 drugs 16 manufacturers
Drugs that treat it
Common Ductal carcinoma in situ of breast therapies.
TAMOXIFEN CITRATE
SOLTAMOX (tamoxifen citrate)
TAMOXIFEN (tamoxifen citrate)
TAMOXIFEN CITRATE
SOLTAMOX (tamoxifen citrate)
TAMOXIFEN CITRATE
TAMOXIFEN CITRATE
SOLTAMOX (tamoxifen citrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDuctal carcinoma in situ of the breast is a non-invasive, pre-invasive neoplastic proliferation of epithelial cells originating within the breast’s ductal-lobular system.
The defining hallmark is the malignant transformation of cells lining the milk ducts without penetration through the basement membrane into the surrounding mammary stroma, lymphatic channels, or blood vessels.
Pathophysiologically categorized as stage 0 breast cancer, it predominantly affects adult women and represents a potential, non-obligate precursor to invasive ductal carcinoma.
Although usually asymptomatic and most often identified by characteristic microcalcifications on screening mammography, the lesion is biologically heterogeneous with variable nuclear grade, architectural patterns, and hormone receptor expression.
- nih.gov
Ductal carcinoma in situ of the breast is a non-invasive, pre-invasive neoplastic proliferation of epithelial cells originating within the breast’s ductal-lobular system The defining hallmark is the malignant transformation of cells lining the milk ducts without penetration through the basement membrane into the surrounding mammary stroma, lymphatic channels, or blood vessels Pathophysiologically categorized as stage 0 breast cancer, it predominantly affects adult women and represents a potentia...
- cancer.org
Ductal carcinoma in situ of the breast is a non-invasive, pre-invasive neoplastic proliferation of epithelial cells originating within the breast’s ductal-lobular system Pathophysiologically categorized as stage 0 breast cancer, it predominantly affects adult women and represents a potential, non-obligate precursor to invasive ductal carcinoma
- komen.org
The defining hallmark is the malignant transformation of cells lining the milk ducts without penetration through the basement membrane into the surrounding mammary stroma, lymphatic channels, or blood vessels
- hopkinsmedicine.org
The defining hallmark is the malignant transformation of cells lining the milk ducts without penetration through the basement membrane into the surrounding mammary stroma, lymphatic channels, or blood vessels
- mskcc.org
Although usually asymptomatic and most often identified by characteristic microcalcifications on screening mammography, the lesion is biologically heterogeneous with variable nuclear grade, architectural patterns, and hormone receptor expression
Personalize your experience
Follow Ductal carcinoma in situ of breast and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.